InvestorsHub Logo
Followers 61
Posts 6981
Boards Moderated 0
Alias Born 10/03/2004

Re: None

Tuesday, 12/15/2009 11:50:02 AM

Tuesday, December 15, 2009 11:50:02 AM

Post# of 229
The Stock Trading Gunslinger?
From: Simen Hatlevik (hatlevik7@hotmail.com)
Sent: Mon 12/14/09 3:08 AM
To: xxxxxxx

Highest rated pick this quarter

Symbol - FROI
Current - .55
Short Target - 1.35+
Long Target - 3.80+
Rating - 10 of 10

According to Yahoo Finance's stock screener, 221 of 294 stocks which are up 200 percent or more in the past 12 months have market capitalizations of less than $100 million. About two-thirds of the rest of these high-flyers have market caps of $100 million-500 million. Biotech is leading the pack.

Last year the World Health Organization warned that ?the level of resistance to drugs used to treat common infectious diseases was reaching a crisis point and, if action was not taken soon, we must anticipate a return to the pre-antibiotic era with the entire population facing a ?superbug? catastrophe for which no effective treatment exists? (British Medical Journal, 320:1624, June 2000). ?Such organisms could make antibiotics useless by as early as 2010.? As a result, society may find itself returning to the days before penicillin, when millions of people routinely died from staph, strep, TB and other bacterial infections.

Buy this stock today, make bigger profits than the Wall Street Traders that have yet to discover FROI. A merger and acquisition mania is now underway in the Biotech/ Pharma space. Many companies are running out of cash as well as credit and some are closing their doors. It?s Capitalism at its? finest. The new kids on the block like FROI, those with world-class management, strong patent pipelines, and access to deal making will survive and prosper. FROI?s growth through acquisition business model, incredible management and advisors, and market timing make the FROI our 5 Star pick of the week. Pyro has also attracted impressive Scientific Advisory Board Members formally with such industry giants such as: Merck, Glaxo, Vertex, Chiron, Abbott, Bristol Myers Squibb, Rhone-Poulenc Rorer, Hoechst Marion Roussel, and Cubist Pharmaceuticals, Inc. The stock is currently trading at the $0.50 level and is poised to explode as future acquisition targets are announced and current targets closed.

Today's Cribsheet

Send stock manipulators to: enforcement@sec.gov-and to jail.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.